Search

everythinglearnresearchcommunity

for

Search:↓

Combining hair transplantation with microneedling or laser and UV light may help treat tough vitiligo on hands and feet, with microneedling being affordable and easy to learn.

Red LED light helps mouse hair grow by increasing growth factors from skin cells.

Microemulsions could improve how drugs are delivered and absorbed in the body.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Changing how mesenchymal stromal cells are grown can improve their healing abilities.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

Beta-sitosterol has potential health benefits but needs more research to fully understand its effects and improve its use in treatments.

Hair follicle stem cells are key for hair and skin regeneration, can be reprogrammed, and have potential therapeutic uses, but also carry a risk of cancer.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Chitosan nanoparticles are promising for sustained caffeine delivery through the skin.

Plant extracts may help prevent or reverse hair graying.

Polycystic ovary syndrome and iron overload share similar symptoms and can be potentially treated with blood removal, diet changes, and probiotics.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

A genetic region near the PAX1 gene is linked to a higher risk of scoliosis in females.

Treatments for melanin disorders exist, but more effective options needed.

Low-Level Light Therapy (LLLT) is a safe and effective method for skin rejuvenation, acne treatment, wound healing, body contouring, and hair growth, but more well-designed trials are needed for confirmation.

The study concludes that mutations in the AEBP1 gene can cause a form of Ehlers-Danlos syndrome and should be considered in diagnosis.

The document suggests reevaluating the patent system to ensure public benefits from pharmaceutical privileges and to encourage more significant innovations.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

UK courts and the European Patent Office are now more open to granting patents for new dosage regimes.

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

K_ATP channel gene mutations are linked to heart diseases, but more research is needed to understand the connection and treatment potential.

Using nanostructured lipid carriers to deliver spironolactone could improve treatment for hair loss.

Brain-Derived Neurotrophic Factor (BDNF) slows down hair growth and promotes hair follicle regression.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

Minoxidil improves blood flow and vessel flexibility, potentially helping with vascular stiffness.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.